STAT3 inhibition enhances gemcitabine sensitivity in pancreatic cancer by suppressing EMT, immune escape and inducing oxidative stress damage
Hangcheng Guo, Zujian Hu, Xuejia Yang, Ziwei Yuan, Yuanyuan Gao, Jiawei Chen, Lili Xie, Chaoyue Chen, Yangyang Guo, Yongheng Bai
Topics & Concepts
GemcitabinePancreatic cancerCancer researchApoptosisSTAT3Immune systemProtein kinase BOxidative stressSignal transductionImmune checkpointBiologyChemistryCancerImmunologyCell biologyImmunotherapyEndocrinologyBiochemistryGeneticsPancreatic and Hepatic Oncology ResearchEpigenetics and DNA MethylationCancer Immunotherapy and Biomarkers